Linda Gallo's research interest is cardiometabolic disease and lifestyle factors that affect this, particularly in relation to nutrition and pregnancy.
Linda’s PhD investigated how low birth weight affects kidney development and the increased risk of high blood pressure and kidney disease in adulthood. Her postdoctoral research focused on a new drug class for diabetes mellitus, SGLT2 inhibitors, and its effects on kidney and heart function.
In 2016, Linda established a research program which combines her speciality areas. This includes the assessment of diet, physical activity, and cardiometabolic health in young adults; maternal dietary intake, supplement use, nutrient status, and obstetric outcomes; and the impact of lockdowns on preterm birth rates.
She collaborates with numerous researchers and clinicians, including those interested in the impacts of adverse prenatal exposures such as alcohol, links between maternal microbiome and pregnancy outcomes, and how diabetes is a risk factor for severe influenza and COVID-19.
Experience
-
2022–presentLecturer, School of Health, University of the Sunshine Coast
-
2020–2022UQ Amplify Fellow, University of Queensland
-
2015–2019NHMRC/Heart Foundation Early Career Fellow, Mater Research-UQ
-
2013–2015Heart Foundation Postdoctoral Fellow, Mater Research
Education
-
2018Deakin University , Grad Cert Human Nutrition
-
2013The University of Melbourne, PhD - physiology
-
2008The University of Melbourne, BSc (Hons)
- Moreton Bay, Australia
- Website
- @LindaAGallo
- Article Feed
- lgallo@usc.edu.au
- ORCID
- Joined
